110
Participants
Start Date
November 30, 2025
Primary Completion Date
July 31, 2026
Study Completion Date
May 15, 2027
Ceftriaxon
Ceftriaxone will not be provided as part of the study. Pregnant participants will receive these drugs as prescribed outside the study by their non-study clinical care provider
Benzathine penicillin G
Benzathine penicillin G will not be provided as part of the study. Pregnant participants will receive these drugs as prescribed outside the study by their non-study clinical care provider
Site 5114, Bronx-Lebanon Hospital Center NICHD CRS, The Bronx
Site 5013, Jacobi Med. Ctr. Bronx NICHD CRS, The Bronx
Site 5040, SUNY Stony Brook NICHD CRS, Stony Brook
Site 5083, Rush Univ. Cook County Hosp. Chicago NICHD CRS, Chicago
Site 4001, Lurie Children's Hospital of Chicago (LCH) CRS, Chicago
Site 5128, Baylor College of Medicine/Texas Children's Hospital NICHD CRS, Houston
Site 5048, USC - Maternal Child Adolescent/Adult Center, Los Angeles
Site 5112, David Geffen School of Medicine at UCLA NICHD CRS, Los Angeles
Site 5129, IMPAACT/Gamma Project/UPR Pediatric HIV/AIDS Research CRS, San Juan
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
National Institute of Mental Health (NIMH)
NIH
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
NETWORK